Intermediate Stage Complex Regional Pain Syndrome Type 1 Is Unrelated to Proinflammatory Cytokines

Bharwani, K. D., Dirckx, M., Stronks, D. L., Dik, W. A., Schreurs, M. W. J., & Huygen, F. J. P. M. (2017). Elevated Plasma Levels of sIL-2R in Complex Regional Pain Syndrome: A Pathogenic Role for T-Lymphocytes?. Mediators of Inflammation, 2017(), 1-6. https://doi.org/10.1155/2017/2764261
Stangelj, M. L. (2013). Mediators of Inflammation as Targets for Chronic Pain Treatment. Mediators of Inflammation, 2013(), 752-754-282. https://doi.org/10.1155/2013/783235
Wesseldijk, F., Huygen, F. J. P. M., Antoissen, C. H., Niehof, S. P., & Zijlstra, F. J. (2008). Six Years Follow-up of the Levels of TNF-α and IL-6 in Patients with Complex Regional Pain Syndrome Type 1. Mediators of Inflammation, 2008(), 215-221. https://doi.org/10.1155/2008/469439
Caso, F., Rigante, D., Vitale, A., Lucherini, O. M., Costa, L., Atteno, M., Compagnone, A., Caso, P., Frediani, B., Galeazzi, M., Punzi, L., & Cantarini, L. (2013). Monogenic Autoinflammatory Syndromes: State of the Art on Genetic, Clinical, and Therapeutic Issues. International Journal of Rheumatology, 2013(), 101-115. https://doi.org/10.1155/2013/513782
黃麗鈴、陳貞吟、劉憶萍、李琴惠（2003）。Investigation of Management of Pain Symptoms of Inpatients with End-stage Cancer。安寧療護雜誌，8(1)，28-35。https://doi.org/10.6537/TJHPC.2003.8(1).3